Pleurodesis treatment with 50% glucose

Phase 3

Recruiting

• Conditions: Malignant pleural effusion.; Malignant pleural effusion; J91.0

• Registration Number: IRCT20201013049017N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Patient with metastatic malignancies cause to pleural effusion.
Diagnosis of malignant pleural effusion based on pleural fluid cytology.
Symptomatic and recurrent pleural effusion due to malignancy.
No history of allergy to bleomycin .

Exclusion Criteria

Reluctance to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Investigation of the location and severity of pleural effusion. Timepoint: Before starting the intervention: Installation of chest tube number F 28 in the area of the hypothetical middle axillary line from the fifth or sixth intercostal space in the appropriate position24 to 48 hours after chest tube implantation: Preparation of chest graph in both face and profile positions. Method of measurement: CT-Scan.